Tirzepatide - First in a new class of diabetes medication (Part 2)

madman

Super Moderator
Tirzepatide is a new class of medication for t2d that activates GIP and glp1 receptors. Endocrinologist Dr. Thomas Blevins (MD, FACE) from Texas Diabetes and Endocrinology, Austin, TX, presents data and practical information for clinicians.


To view this content we will need your consent to set third party cookies.
For more detailed information, see our cookies page.

Screenshot (18550).png
 


 
@madman Does Tirzepatide affect or try to alter glucose in the liver?

The reason I ask is because any time I attemp a drug that tried to alter glucose in the liver results is a potassium deficiency within 24 hours.
 

Online statistics

Members online
4
Guests online
345
Total visitors
349

Latest posts

Back
Top